BRIEF published on 08/01/2024 at 17:31, 3 months 21 days ago Cairn Homes Plc: Changes in Major Shareholdings Voting Rights Stock Market Cairn Homes Major Shareholding T. Rowe Price
PRESS RELEASE published on 08/01/2024 at 17:26, 3 months 21 days ago Cairn Homes Plc: Holding(s) in Company T. Rowe Price Associates, Inc. notifies major holdings in Cairn Homes Plc, crossing 4% threshold on 30 July 2024. Notification submitted on 01 August 2024 Cairn Homes Plc Major Holdings Notification T. Rowe Price Associates 4% Threshold
BRIEF published on 08/01/2024 at 13:45, 3 months 21 days ago Cairn Homes Plc: Total Voting Rights Update Ordinary Shares Cairn Homes Plc Total Voting Rights Regulatory Announcement Transparency Directive
PRESS RELEASE published on 08/01/2024 at 13:40, 3 months 21 days ago Cairn Homes Plc: Total Voting Rights Cairn Homes Plc confirms total voting rights as 639,812,999 Ordinary Shares with one vote each. Shareholders use 639,812,999 as denominator for Transparency Regulations Shareholders Ordinary Shares Cairn Homes Plc Total Voting Rights Transparency Regulations
BRIEF published on 08/01/2024 at 08:05, 3 months 21 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Euronext Dublin Cairn Homes
PRESS RELEASE published on 08/01/2024 at 08:00, 3 months 21 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc repurchases 100,000 of its own shares on Euronext Dublin and the London Stock Exchange as part of a share buyback program Share Buyback Program Cairn Homes Plc Euronext Dublin Repurchase Own Shares
BRIEF published on 07/31/2024 at 08:05, 3 months 22 days ago Cairn Homes Plc: Transaction in Own Shares Share Buyback Stock Exchange Cairn Homes Financial Transaction Goodbody Stockbrokers
PRESS RELEASE published on 07/31/2024 at 08:00, 3 months 22 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces transaction in own shares, purchasing 100,000 ordinary shares on Euronext Dublin and London Stock Exchange. Shares will be cancelled as part of share buyback program London Stock Exchange Shares Cairn Homes Plc Euronext Dublin Transaction
BRIEF published on 07/30/2024 at 08:05, 3 months 23 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Euronext Dublin Goodbody Stockbrokers
PRESS RELEASE published on 07/30/2024 at 08:00, 3 months 23 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase of 100,000 of its ordinary shares through a buyback program, enhancing shareholder value London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
Published on 11/22/2024 at 23:55, 6 hours 55 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 7 hours 20 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 7 hours 45 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 8 hours 20 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 12 hours 36 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 12 hours 57 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 13 hours 55 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 14 hours 50 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 11 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 13 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 13 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
